We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Exhaled Nitric Oxide and Eosinophil Count Diagnose Eosinophilic Asthma

By LabMedica International staff writers
Posted on 01 Sep 2021
Print article
Image: Blood film showing eosinophilic leukocytes (single cell arrowed) surrounded by red blood cells. About 50% of people with severe asthma may have elevated levels of eosinophils in their blood (Photo courtesy of Jane Liesveld, MD)
Image: Blood film showing eosinophilic leukocytes (single cell arrowed) surrounded by red blood cells. About 50% of people with severe asthma may have elevated levels of eosinophils in their blood (Photo courtesy of Jane Liesveld, MD)
Eosinophilic asthma is now recognized as an important subphenotype of asthma based on the pattern of inflammatory cellular infiltrate in the airway. Eosinophilic asthma can be associated with increased asthma severity, atopy, late-onset disease, and steroid refractoriness.

Asthma is characterized by recurrent respiratory symptoms and a variable expiratory-airflow limitation, affecting approximately 334 million people worldwide. Tests to identify reversible airflow limitation are important in asthma diagnosis, but they are time-consuming and it may be difficult for patients to cooperate.

Respiratory Medicine specialists at the Daping Hospital, Army Medical University (Chongqing, China) conducted a retrospective cohort study on 2,349 suspected asthma cases between January 2014 and December 2019. Fractional exhaled nitric oxide (FeNO) was evaluated with an online measurement technique using a Nano Coulomb nitric oxide analyzer. FeNO results were reported as parts per billion (ppb), and FeNO measurements were performed prior to spirometry, the methacholine challenge test, and the reversibility test.

The investigators took peripheral venous blood samples, and blood eosinophils (B-Eos) and leukocytes were counted using a Sysmex XN‐9000 Hematology Analyzer (Sysmex, Kobe, Japan), a multifunctional automatic hematology analyzer and leukocyte classifier. B-Eos counts were reported along with other leukocyte subpopulations, and the percentage of each subpopulation was calculated. Baseline spirometry, the bronchial-provocation and bronchodilation test (BPT, BDT) were performed using a Jaeger spirometer (Erich Jaeger GmbH, Würzburg, Germany).

The scientists reported that the main study population included 897 males and 1,452 females, of whom 824 patients were diagnosed with asthma. Asthmatic patients had significantly higher white blood cell counts (7.24 versus 7.05 × 109/L), B-Eos counts (306 versus 105 cells/μL), B-Eos percentages (4.5% versus 1.8%), and FeNO levels (52 versus 5 ppb). The percentage of blood neutrophils, forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and FEV1/FVC ratio of asthmatic patients were significantly lower (59.3% versus 61.9%, 94.4% versus 96.2%, 79.7% versus 92.4%, and 68.5% versus 80.2%), respectively. The odds ratio for having asthma increased progressively with a gradual increase in FeNO or B-Eos count.

The authors concluded that there was no difference in diagnostic accuracy for asthma between FeNO and B-Eos count, and the combination of these two biomarkers could slightly improve diagnostic efficacy. Patients with moderately elevated biomarkers (FeNO > 40 ppb and B-Eos > 300 cells/μL) could be diagnosed with asthma and avoid objective tests when such tests are not feasible. The study was published on August 9, 2021 in the journal BMC Pulmonary Medicine.

Related Links:
Daping Hospital, Army Medical University
Sysmex
Erich Jaeger GmbH


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.